Tobramycin

FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments

This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s

Top Pharma & Biotech Deals, Investments, M&As in September 2018

As compared to the previous months, September was a slower month for dealmaking. The Wall Street J

GSK, Google form first bioelectronics firm; 11 generic companies benefit from the Teva Allergan deal

This week, Phispers brings to you the details of the bioelectronics firm formed by GSK and Google. T

Data integrity has no relationship with product quality

Peter J. Werth, President and Chief Executive Officer, ChemWerth, a US-headquartered full-service ge